Abbott Laboratories (NYSE:ABT)

84.27
Delayed Data
As of Sep 13
 -0.94 / -1.10%
Today’s Change
65.44
Today|||52-Week Range
88.76
+16.51%
Year-to-Date
Abbott Sees Hammer Chart Pattern: Time to Buy?
Sep 11 / Zacks.com - Paid Partner Content
Here's Why You Should Hold on to Thermo Fisher (TMO) for Now
Sep 03 / Zacks.com - Paid Partner Content
Abbott (ABT) Stock Sinks As Market Gains: What You Should Know
Sep 10 / Zacks.com - Paid Partner Content
5 Cancer-Fighting Stocks to Add to Your Portfolio
Sep 03 / Zacks.com - Paid Partner Content
Abbott (ABT) Launches Pivotal Trial TRILUMINATE in the US
Sep 09 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close85.21
Today’s open85.30
Day’s range83.89 - 85.36
Volume3,633,221
Average volume (3 months)4,898,612
Market cap$148.9B
Data as of 6:30pm ET, 09/13/2019

Growth & Valuation

Earnings growth (last year)+397.55%
Earnings growth (this year)+12.68%
Earnings growth (next 5 years)+11.16%
Revenue growth (last year)+11.64%
P/E ratio52.0
Price/Sales4.19
Price/Book4.85

Competitors

 Today’s
change
Today’s
% change
BDXBecton Dickinson and...-1.45-0.55%
BSXBoston Scientific Co...-0.43-1.02%
BAXBaxter International...-0.89-1.01%
ZBHZimmer Biomet Holdin...-3.82-2.68%
Data as of 6:30pm ET, 09/13/2019

Financials

Next reporting dateOctober 18, 2019
EPS forecast (this quarter)$0.84
Annual revenue (last year)$30.6B
Annual profit (last year)$2.4B
Net profit margin7.58%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Miles D. White
President &
Chief Operating Officer
Robert B. Ford
Corporate headquarters
Abbott Park, Illinois

Forecasts